Evidence map›Paper›PMID 40842820›Full record

ArticleFrontiers in molecular biosciences2025

Shared molecular profiles of post-laser vision correction ectasia and keratoconus with key differences in

Katarzyna Jaskiewicz-Rajewicz, Alicja Wysocka, Magdalena Maleszka-Kurpiel, Eliza Matuszewska-Mach, Jakub Wozniak, Rafal Ploski, Jan Matysiak, Malgorzata Rydzanicz, Marzena Gajecka

Abstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Katarzyna Jaskiewicz-Rajewicz *Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Alicja Wysocka *Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Magdalena Maleszka-KurpielOptegra Eye Healthcare Clinic in Poznan, Poznan, Poland.
Eliza Matuszewska-MachChair and Department of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, Poznan, Poland.
Jakub WozniakChair and Department of Genetics and Pharmaceutical Microbiology, Poznan University of Medical Sciences, Poznan, Poland.
Rafal PloskiDepartment of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.
Jan MatysiakChair and Department of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, Poznan, Poland.
Malgorzata RydzaniczDepartment of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.
Marzena GajeckaInstitute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Post-laser vision correction (post-LVC) ectasia is a serious complication that is observed in 0.033%-0.66% of corneal refractive surgeries. Similar to keratoconus (KTCN), post-LVC ectasia is classified under the category of "ectatic diseases." We hypothesize that although the mechanistic aspects of post-LVC ectasia and KTCN are distinct, there are notable similarities in the epithelial responses, including shared molecular features. Methods: A total of 11 post-LVC ectasia, 8 mild myopia (controls), and 28 KTCN patients were included in a retrospective multiomics case-control study. The corneal epithelium (CE) samples obtained from the subjects were separated into different Results: The residual stromal bed, stromal ablation depth, and percent tissue altered indices were found to best predict the risk of post-LVC ectasia. From comparisons of post-LVC ectasia and KTCN, interferon-alpha and interferon-gamma hallmarks were found to be downregulated in the Discussion: The assessment of

Indexed as

corneal epitheliumkeratoconuspost-laser vision correction ectasiapost-LASIK ectasiapost-SMILE ectasiaproteomicstranscriptomics

Identifiers

PMID40842820
PMCPMC12364684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.